We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR-Cas9 Corrects Mutations in Muscular Dystrophy Patients' Cells

News   Jan 31, 2018 | Original Story by Ruairi J Mackenzie, Science Writer for Technology Networks

 
CRISPR-Cas9 Corrects Mutations in Muscular Dystrophy Patients' Cells

Members of the research team are pictured alongside a DMD patient and their family. Credit: UT Southwestern Medical Center

Ruairi MacKenzie

Science Writer

 
 
 

RELATED ARTICLES

Novel Histone-Tracking Tool Unlocks New Insights into Epigenetic Cellular Memory

News

The way daughter cells inherit histones is a highly controlled process, and may be highly influential on development.

READ MORE

Retinoic Acid may Improve Immune Response Against Melanoma

News

Scientists have found a promising strategy to remove one of melanoma’s most powerful defenses, leading to more immune system activity directed at melanoma.

READ MORE

PCR Assay Helps ID Sarcoma Mutations

News

Sarcomas are rare tumors that are often misdiagnosed. A report in the Journal of Molecular Diagnostics describes a new assay, anchored multiplex PCR (AMP)-based targeted next-generation-sequencing (NGS), that is better able to identify genetic diagnostic markers of the cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE